Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON33799Phase 4Active, not recruiting
Phase 4, randomised, double-blind trial in asthma comparing Foster with Seretide Diskus (2 arms). Primary endpoint: Pre-dose morning forced expiratory volume in one second (FEV1) at last clinic visit. Started May 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON33799.